BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21896933)

  • 21. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calpain-10 gene polymorphisms in type 2 diabetes and its micro- and macrovascular complications.
    Buraczynska M; Wacinski P; Stec A; Kuczmaszewska A
    J Diabetes Complications; 2013; 27(1):54-8. PubMed ID: 23021796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between mannose-binding lectin and vascular complications in type 1 diabetes.
    Hansen TK; Tarnow L; Thiel S; Steffensen R; Stehouwer CD; Schalkwijk CG; Parving HH; Flyvbjerg A
    Diabetes; 2004 Jun; 53(6):1570-6. PubMed ID: 15161763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.
    Kaunisto MA; Sjölind L; Sallinen R; Pettersson-Fernholm K; Saraheimo M; Fröjdö S; Forsblom C; Fagerudd J; Hansen TK; Flyvbjerg A; Wessman M; Groop PH;
    Diabetes; 2009 Jul; 58(7):1710-4. PubMed ID: 19366862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.
    Sambo F; Malovini A; Sandholm N; Stavarachi M; Forsblom C; Mäkinen VP; Harjutsalo V; Lithovius R; Gordin D; Parkkonen M; Saraheimo M; Thorn LM; Tolonen N; Wadén J; He B; Osterholm AM; Tuomilehto J; Lajer M; Salem RM; McKnight AJ; ; Tarnow L; Panduru NM; Barbarini N; Di Camillo B; Toffolo GM; Tryggvason K; Bellazzi R; Cobelli C; ; Groop PH
    Diabetologia; 2014 Aug; 57(8):1611-22. PubMed ID: 24871321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The FTO variant is associated with chronic complications of diabetes mellitus in Czech population.
    Hubacek JA; Dlouha D; Klementova M; Lanska V; Neskudla T; Pelikanova T
    Gene; 2018 Feb; 642():220-224. PubMed ID: 29154870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients.
    Hu C; Zhang R; Yu W; Wang J; Wang C; Pang C; Ma X; Bao Y; Xiang K; Jia W
    Diabetes; 2011 Nov; 60(11):3085-9. PubMed ID: 21911749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.
    Brasacchio D; Okabe J; Tikellis C; Balcerczyk A; George P; Baker EK; Calkin AC; Brownlee M; Cooper ME; El-Osta A
    Diabetes; 2009 May; 58(5):1229-36. PubMed ID: 19208907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe).
    Sobrin L; Green T; Sim X; Jensen RA; Tai ES; Tay WT; Wang JJ; Mitchell P; Sandholm N; Liu Y; Hietala K; Iyengar SK; ; Brooks M; Buraczynska M; Van Zuydam N; Smith AV; Gudnason V; Doney AS; Morris AD; Leese GP; Palmer CN; ; Swaroop A; Taylor HA; Wilson JG; Penman A; Chen CJ; Groop PH; Saw SM; Aung T; Klein BE; Rotter JI; Siscovick DS; Cotch MF; Klein R; Daly MJ; Wong TY
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7593-602. PubMed ID: 21873659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
    Klein RL; Hunter SJ; Jenkins AJ; Zheng D; Semler AJ; Clore J; Garvey WT;
    Diabetes Care; 2003 May; 26(5):1439-48. PubMed ID: 12716802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].
    Corrêa-Giannella ML; Vieira SM
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):375-86. PubMed ID: 18438549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
    Hodgkinson AD; Page T; Millward BA; Demaine AG
    J Diabetes Complications; 2005; 19(2):65-9. PubMed ID: 15745834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes.
    Hoverfelt A; Sallinen R; Söderlund JM; Forsblom C; Pettersson-Fernholm K; Parkkonen M; Groop PH; Wessman M;
    Diabetologia; 2010 Sep; 53(9):1903-7. PubMed ID: 20490454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes.
    Ray D; Mishra M; Ralph S; Read I; Davies R; Brenchley P
    Diabetes; 2004 Mar; 53(3):861-4. PubMed ID: 14988276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
    Kao Y; Donaghue KC; Chan A; Bennetts BH; Knight J; Silink M
    Diabet Med; 2002 Mar; 19(3):212-5. PubMed ID: 11918623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide meta-analysis for severe diabetic retinopathy.
    Grassi MA; Tikhomirov A; Ramalingam S; Below JE; Cox NJ; Nicolae DL
    Hum Mol Genet; 2011 Jun; 20(12):2472-81. PubMed ID: 21441570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with Type 1 diabetes consuming alcoholic spirits have an increased risk of microvascular complications.
    Harjutsalo V; Feodoroff M; Forsblom C; Groop PH;
    Diabet Med; 2014 Feb; 31(2):156-64. PubMed ID: 23952587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy.
    Ciccacci C; Di Fusco D; Cacciotti L; Morganti R; D'Amato C; Novelli G; Sangiuolo F; Spallone V; Borgiani P
    Acta Diabetol; 2013 Oct; 50(5):789-99. PubMed ID: 22843023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.